Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Hepatic Surgery(Electronic Edition) ›› 2020, Vol. 09 ›› Issue (06): 582-586. doi: 10.3877/cma.j.issn.2095-3232.2020.06.018

Special Issue:

• Clinical Research • Previous Articles     Next Articles

Safety and clinical efficacy of EmprintTM microwave ablation system for hepatocellular carcinoma

Xiaodan Zhang1, Huolin Ye1, Yating Su1, Qingjin Zeng1, Xuqi He1, Kai Li1, Rongqin Zheng1, Erjiao Xu2,()   

  1. 1. Department of Ultrasound, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Medical Ultrasonics, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, China
  • Received:2020-07-20 Online:2020-12-10 Published:2020-12-10
  • Contact: Erjiao Xu

Abstract:

Objective

To evaluate the safety and clinical efficacy of EmprintTM microwave ablation system with ThermosphereTM technology in the treatment of hepatocellular carcinoma (HCC).

Methods

Clinical data of 24 HCC patients admitted to the Third Affiliated Hospital of Sun Yat-sen University from January 2019 to May 2019 were retrospectively analyzed. Among them, 18 patients were male and 6 female, aged (52±11) years on average. The informed consents of all patients were obtained and the local ethical committee approval was received. The microwave ablation was performed with EmprintTM microwave ablation system with an ablation power of 100 W. According to different ablation time of the first insertion, all lesions were divided into the 5-min and 10-min groups. The ablation range of first insertion was assessed by intraoperative contrast-enhanced ultrasound (CEUS). Complete ablation rate and the incidence of major complications induced by ablation were observed at postoperative 1 month. The ablation range of first insertion was compared between two groups by t test.

Results

27 lesions from 24 patients were ablated with real-time ultrasound-guided EmprintTM microwave ablation system, including 11 lesions in the 5-min group and 16 lesions in the 10-min group. The median ablation frequency was 2(1-7) times, and the total ablation time was 10(5-45) min. In the 5-min group, the maximal diameter of ablated lesions was (29.3±2.6) mm, significantly shorter than (33.7±6.7) mm in the 10-min group (t=-2.389, P<0.05). The transverse diameter, round index and ablation area in the 5-min group were (25.8±3.0) mm, 0.88±0.10, (2 384±406) mm2, which did not significantly differ from (27.0±6.3) mm, 0.81±0.14 and (2 939±1 091) mm2 in the 10-min group (t=-0.657, 1.518, -1.857; P>0.05). Enhanced CT scan or MRI at postoperative 1 month showed that 25 lesions were completely ablated with a complete ablation rate of 100% except 2 cases who did not receive reexamination. Reexamination revealed no major complications related to ablation.

Conclusions

EmprintTM microwave ablation system is a safe and effective method for HCC. 5-min ablation with a power of 100 W can obtain more regular and predictable spherical ablation range compared with 10-min ablation.

Key words: Carcinoma, hepatocellular, Microwave ablation, Round index

京ICP 备07035254号-20
Copyright © Chinese Journal of Hepatic Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-85252582 85252369 E-mail: chinaliver@126.com
Powered by Beijing Magtech Co. Ltd